TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Hedy L Kindler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.